Global Bioprocessing Equipment Market Size is valued at USD 64.6 Bn in 2024 and is predicted to reach USD 159.2 Bn by the year 2034 at a 9.7% CAGR during the forecast period for 2025-2034. The specialized instruments and systems used in the manufacturing of biological products, including vaccines, monoclonal antibodies, enzymes, and biopharmaceuticals, are referred to as bioprocessing equipment. Typically, several intricate procedures are employ...
Report ID: 3125 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 170
Global Self-Amplifying RNA Synthesis Market Size is valued at USD 115.1 Mn in 2024 and is predicted to reach USD 715.6 Mn by the year 2034 at a 20.4% CAGR during the forecast period for 2025-2034. RNA that self-replicates in cells is generated through self-amplifying RNA (saRNA) synthesis, which enhances protein production for the purposes of immunotherapy, gene therapy, and vaccine manufacture. The procedure entails the design of a D...
Report ID: 3123 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 170
Global Flow Injection Analyzer Market Size is valued at USD 1.1 Bn in 2024 and is predicted to reach USD 2.3 Bn by the year 2034 at a 7.6% CAGR during the forecast period for 2025-2034. A Flow Injection Analyzer (FIA) is an automated device for quick chemical analysis. It injects a tiny sample (10–100 µL) into a flowing liquid stream, where it mixes with reagents, reacts, and is measured by detectors like UV-Vis or electrochemical se...
Report ID: 3118 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 170
Global Cell Culture Vitamins Market Size is valued at USD 243.3 Mn in 2024 and is predicted to reach USD 456.2 Mn by the year 2034 at a 6.8% CAGR during the forecast period for 2025-2034. Cell culture vitamins are incorporated into culture media to enhance the growth, proliferation, and functioning of cells maintained in vitro. These vitamins are crucial for numerous cellular functions, encompassing DNA synthesis, enzymatic activity, ...
Report ID: 3102 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 160
The Allogeneic Cell Therapy Manufacturing Market is expected to grow at a 15.0 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The rise in chronic conditions such as cancer, autoimmune disorders, and cardiovascular diseases is a major driver. The expanding use of allogeneic cell therapies across a wide range of medical conditions, including dermatological, neur...
Report ID: 1194 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 170
Microbiology Reagents Market Size is valued at USD 3.01 Bn in 2024 and is predicted to reach USD 5.46 Bn by the year 2034 at a 6.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The high burden of infectious diseases is a major driver behind the increasing demand for microbiology reagents. Advances in the field of life sciences and biotechnology are significantly bo...
Report ID: 2409 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 179
Primary Cells Market Size is valued at USD 1.94 Bn in 2024 and is predicted to reach USD 5.18 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Primary cells are cells isolated from a living organism as opposed to "cell lines," which have been grown for a long time and are frequently employed in various biological and medical research purposes. Because they more closely resemble cells in living organisms and p...
Report ID: 2112 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 179
Genomic Cancer Testing Market Size is valued at USD 18.47 billion in 2024 and is predicted to reach USD 86.13 billion by the year 2034 at a 16.8% CAGR during the forecast period for 2025-2034. Genomic cancer testing examines the DNA of cancer cells to detect hereditary abnormalities. This data informs individualized treatment strategies, such as precision medicines, tailored to the tumour's specific genetic characteristics. It offers predictiv...
Report ID: 2267 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 179
Bispecific Antibody Therapeutics Contract Manufacturing Market Size is valued at US$ 9.25 Bn in 2024 and is predicted to reach US$ 149.65 Bn by the year 2034 at an 32.2% CAGR during the forecast period for 2025-2034. Bispecific antibodies are highly preferred in therapeutic approaches. These antibody therapeutics provide many therapeutic benefits and help meet the patient's unmet needs. In addition, the therapeutic potential to treat cancer, dia...
Report ID: 1996 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
EV-based Liquid Biopsy Market Size is valued at 102.13 Million in 2024 and is predicted to reach 572.43 Million by the year 2034 at an 19.0% CAGR during the forecast period for 2025-2034. EVs (Extracellular Vesicles) can be categorized based on their cellular origin or size. EVs derived from the intracellular endosomal system are called "exosomes", and vesicles from the plasma membrane are known as "ectosomes" or "microvesicles". Extracellular v...
Report ID: 1920 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Pharmaceuticals